Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Food Sci ; 74(8): H253-8, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19799667

ABSTRACT

Black-colored rice (BCR), the main constituent of which is cyanidin-3-O-beta-D-glucoside (C3G), exhibits an anti-allergic effect, and orally administered C3G is mainly metabolized to protocatechuic acid in rats. Therefore, to understand the relationship between the metabolism of C3G and its pharmacological effect, we isolated C3G from BCR, anaerobically incubated it with fecal microflora, investigated its metabolite(s) by LC-MS/MS, and measured the antiscratching behavioral effects of C3G and its metabolites. C3G was metabolized to protocatechuic acid via cyanidin. Protocatechuic acid and cyanidin were identified as the metabolites. The activities transforming C3G to protocatechuic acid and cyanidin were 28.2 +/- 11.7 and 21.8 +/- 5.2 nmol/h/mg fecal microflora, respectively. C3G and its metabolites showed inhibitory effects against histamine- or compound 48/80-induced scratching behaviors in mice. C3G more potently inhibited scratching behaviors following oral administration than following intraperitoneal administration. However, protocatechuic acid and cyanidin showed more potent inhibition when administered intraperitoneally than when administered orally. These metabolites also inhibited the expression of allergic cytokines, IL-4 and TNF-alpha, and the activation of their transcription factor, NF-kappaB, in RBL-2H3 cells stimulated with IgE-antigen. These findings suggest that C3G-rich BCR may be a beneficial food for diseases involving scratching behaviors, such as chronic dermatitis, rhinitis, and psoriasis.


Subject(s)
Anthocyanins/metabolism , Anthocyanins/pharmacology , Anti-Allergic Agents/metabolism , Anti-Allergic Agents/pharmacology , Glucosides/metabolism , Glucosides/pharmacology , Oryza/chemistry , Pruritus/drug therapy , Seeds/chemistry , Animals , Anthocyanins/biosynthesis , Anthocyanins/isolation & purification , Anti-Allergic Agents/isolation & purification , Cell Degranulation/drug effects , Cell Line, Tumor , Dose-Response Relationship, Drug , Glucosides/isolation & purification , Humans , Hydroxybenzoates/isolation & purification , Hydroxybenzoates/metabolism , Hydroxybenzoates/pharmacology , Interleukin-4/metabolism , Male , Mice , Mice, Inbred BALB C , Mice, Inbred ICR , NF-kappa B/metabolism , Pruritus/chemically induced , Pruritus/prevention & control , Rats , Tumor Necrosis Factor-alpha/metabolism
2.
J Vet Diagn Invest ; 21(3): 377-80, 2009 May.
Article in English | MEDLINE | ID: mdl-19407094

ABSTRACT

A 14-year-old Quarter Horse with a 48-hr history of colic was euthanized after failure to respond to treatment. At necropsy, cecal and colonic mucosae were congested throughout, and there was segmental edema and significant thickening of the intestinal wall. Excessive numbers of mononuclear cells were found in mucosal lamina propria. Submucosal hemorrhage was diffuse and extensive, and Clostridium difficile toxins A and B were detected. Large numbers of C. difficile were isolated, and genetic characterization revealed them to be North American pulsed-field gel electrophoresis type 1, polymerase chain reaction ribotype 027, and toxinotype III. Genes for the binary toxin were present, and toxin negative-regulator tcdC contained an 18-bp deletion. This genotype comprises the current human "epidemic strain," which is associated with human C. difficile-associated disease of greater than historical severity. The diagnosis was peracute typhlocolitis, with lesions and history typical of those attributed to colitis X.


Subject(s)
Clostridioides difficile/classification , Clostridium Infections/veterinary , Colitis/veterinary , Horse Diseases/microbiology , Animals , Clostridium Infections/microbiology , Clostridium Infections/pathology , Colitis/microbiology , Colitis/pathology , Enteritis/microbiology , Enteritis/veterinary , Horse Diseases/pathology , Horses
3.
Vet Microbiol ; 133(1-2): 92-7, 2009 Jan 01.
Article in English | MEDLINE | ID: mdl-18635321

ABSTRACT

Necrotic enteritis (NE) in poultry has re-emerged as a concern for poultry producers, due in part to banning, by many countries, of the use of antimicrobial growth promoters in feeds. This re-emergence has led to a search for alternative methods for control of the disease, particularly vaccination. The objective of this work was to determine if vaccination of broiler chicks with recombinant alpha toxin protected against experimental challenge. Broiler chicks were vaccinated subcutaneously at 5 and 15 days of age, followed 10 days later by challenge with Clostridium perfringens. Birds were challenged twice daily on 4 consecutive days by mixing C. perfringens cultures with feed (three parts culture: four parts feed). Non-vaccinated birds challenged with C. perfringens developed NE at the rate of 87.8%, while only 54.9% of vaccinated birds developed lesions. In addition, non-vaccinated birds had lesion scores averaging 2.37, while average scores in vaccinated birds were 1.35. Vaccination produced an antibody response, with post-vaccination anti-alpha toxin IgG (IgY) titers in vaccinated birds more than 5-fold greater than in non-vaccinated birds. After challenge, vaccinated birds had average IgG (IgY) titers>15-fold higher than those in non-vaccinated birds. These results suggest that alpha toxin may serve as an effective immunogen, and, as such, may play a role in pathogenesis.


Subject(s)
Bacterial Toxins/immunology , Calcium-Binding Proteins/immunology , Chickens , Clostridium Infections/veterinary , Clostridium perfringens/immunology , Poultry Diseases/prevention & control , Type C Phospholipases/immunology , Vaccination/veterinary , Animals , Antibodies, Bacterial/blood , Bacterial Toxins/administration & dosage , Bacterial Vaccines/administration & dosage , Bacterial Vaccines/immunology , Calcium-Binding Proteins/administration & dosage , Chickens/immunology , Clostridium Infections/immunology , Clostridium Infections/pathology , Clostridium Infections/prevention & control , Enteritis/immunology , Enteritis/pathology , Enteritis/prevention & control , Enteritis/veterinary , Female , Immunoglobulin G/blood , Necrosis/immunology , Necrosis/pathology , Necrosis/prevention & control , Necrosis/veterinary , Poultry Diseases/immunology , Poultry Diseases/microbiology , Poultry Diseases/pathology , Random Allocation , Severity of Illness Index , Type C Phospholipases/administration & dosage , Vaccination/methods
4.
J Bacteriol ; 188(20): 7297-305, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17015669

ABSTRACT

Clostridium difficile is the most frequent cause of nosocomial diarrhea worldwide, and recent reports suggested the emergence of a hypervirulent strain in North America and Europe. In this study, we applied comparative phylogenomics (whole-genome comparisons using DNA microarrays combined with Bayesian phylogenies) to model the phylogeny of C. difficile, including 75 diverse isolates comprising hypervirulent, toxin-variable, and animal strains. The analysis identified four distinct statistically supported clusters comprising a hypervirulent clade, a toxin A(-) B(+) clade, and two clades with human and animal isolates. Genetic differences among clades revealed several genetic islands relating to virulence and niche adaptation, including antibiotic resistance, motility, adhesion, and enteric metabolism. Only 19.7% of genes were shared by all strains, confirming that this enteric species readily undergoes genetic exchange. This study has provided insight into the possible origins of C. difficile and its evolution that may have implications in disease control strategies.


Subject(s)
Clostridioides difficile/classification , Clostridioides difficile/pathogenicity , Genome, Bacterial , Phylogeny , Animals , Bacterial Adhesion/genetics , Bacterial Toxins/genetics , Clostridioides difficile/genetics , Clostridioides difficile/physiology , Cluster Analysis , DNA, Bacterial/genetics , Drug Resistance, Bacterial/genetics , Gene Transfer, Horizontal , Genome, Bacterial/genetics , Genomic Islands , Humans , Movement , Nucleic Acid Hybridization , Oligonucleotide Array Sequence Analysis , Virulence
5.
Blood ; 108(5): 1668-76, 2006 Sep 01.
Article in English | MEDLINE | ID: mdl-16645163

ABSTRACT

To determine whether the PI3K/Akt signaling pathway is involved in the pathogenesis of mantle cell lymphoma (MCL), we investigated the phosphorylation status of Akt and multiple downstream targets in primary MCL cases and cell lines. Akt was phosphorylated in 12 of 12 aggressive blastoid MCL variants and in 4 of 4 MCL cell lines. In contrast, phosphorylated Akt was present in only 5 of 16 typical MCL, 3 at comparable levels to the blastoid cases, and 2 at low levels. The presence of p-Akt was accompanied by the phosphorylation of p27(kip1), FRKHL-1, MDM2, Bad, mTOR, and p70S6K. Inhibition of the PI3K/Akt pathway in the MCL cell lines abrogated or reduced the phosphorylation of Akt, p27(kip1), FRKHL-1, MDM2, Bad, mTOR, GSK-3beta, IkappaB, and led to cell-cycle arrest and apoptosis. Six MCL cases (5 with activated Akt and 1 with inactive Akt) and 3 of 4 cell lines showed loss of PTEN expression. PIK3CA mutations were not detected. We conclude that constitutive activation of the PI3K/Akt pathway contributes to the pathogenesis of MCL and preferentially occurs in blastoid variants. One possible mechanism of activation is loss of PTEN expression. These data suggest that PI3K/Akt inhibitors may be effective in the treatment of Akt-activated MCL.


Subject(s)
Lymphoma, Mantle-Cell/pathology , Proto-Oncogene Proteins c-akt/metabolism , Cell Cycle , Cell Division , Cell Line, Tumor , Cell Survival , DNA Mutational Analysis , Enzyme Activation , Humans , Lymphoma, Mantle-Cell/enzymology , Lymphoma, Mantle-Cell/genetics , NF-kappa B/metabolism , Oligonucleotide Array Sequence Analysis , Phosphatidylinositol 3-Kinases/genetics , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation , Proto-Oncogene Proteins c-akt/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...